Current role
Matthew Lang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lyell Immunopharma, Inc. (LYEL)
Proxy statement
Current -
Lyell Immunopharma, Inc. (LYEL)
Proxy statement
Start not stated–2025-04-13
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lyell Immunopharma, Inc. (LYEL) | Chief Business Officer | $516,423 | $1,869,632 |
| 2023 | Lyell Immunopharma, Inc. (LYEL) | Chief Business Officer | $250,000 | $4,008,353 |
| 2022 | Lyell Immunopharma, Inc. (LYEL) | Chief Business Officer | — | — |
| 2021 | Lyell Immunopharma, Inc. (LYEL) | Chief Business Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.